Literature DB >> 2785478

Cirrhotics with variceal hemorrhage: the importance of the time interval between admission and the start of analysis for survival and rebleeding rates.

A K Burroughs1, G Mezzanotte, A Phillips, P A McCormick, N McIntyre.   

Abstract

The importance of variable time of entry for analysis of survival following variceal bleeding has recently been disputed. In a study of 194 cirrhotic patients with bleeding esophageal varices in whom 2-day mortality was 3%, statistically significant differences in both survival and rebleeding rates were obtained by shifting the starting point for analysis of survival by 2 weeks following admission to hospital or by 5 days for the analysis of rebleeding. In addition, the curve of hazard function for death or for failure to control bleeding following admission clearly showed that any change in entry time in a study of variceal bleeding would introduce bias and alter survival or rebleeding rates. Thus, the starting point for analysis following variceal hemorrhage is an important confounding variable when calculating both survival and rebleeding. It should always be taken into account, particularly in clinical trials, which are often performed in centers where patients are referred from other hospitals at different times following bleeding.

Entities:  

Mesh:

Year:  1989        PMID: 2785478     DOI: 10.1002/hep.1840090602

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  27 in total

Review 1.  Acute variceal bleeding: general management.

Authors:  D Patch; L Dagher
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

2.  Epistaxis: an overlooked cause of massive haematemesis in cirrhosis.

Authors:  Shawinder S Johal; Andrew S Austin; Stephen D Ryder
Journal:  BMJ       Date:  2003-02-22

3.  Evaluation of endoscopic variceal ligation (EVL) versus propanolol plus isosorbide mononitrate/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients.

Authors:  Shiv K Sarin; Manav Wadhawan; Rajesh Gupta; Hansa Shahi
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

4.  Adjusted blood requirement index as indicator of failure to control acute variceal bleeding.

Authors:  Marko Duvnjak; Neven Barsić; Vedran Tomasić; Lucija Virović Jukić; Ivan Lerotić; Tajana Pavić
Journal:  Croat Med J       Date:  2006-06       Impact factor: 1.351

5.  Management of digestive bleeding related to portal hypertension in cirrhotic patients: A French multicenter cross-sectional practice survey.

Authors:  Pierre Ingrand; Jerome Gournay; Pierre Bernard; Frederic Oberti; Brigitte Bernard-Chabert; Arnault Pauwels; Philippe Renard; Eric Bartoli; Jean-Francois Cadranel; Jean-Claude Barbare; Isabelle Ingrand; Michel Beauchant
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

6.  Improved prognosis of cirrhosis patients with esophageal varices and thrombocytopenia treated by endoscopic variceal ligation plus partial splenic embolization.

Authors:  Kenji Ohmoto; Naoko Yoshioka; Yasuyuki Tomiyama; Norikuni Shibata; Michihiko Takesue; Koji Yoshida; Makoto Kuboki; Shinichiro Yamamoto
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

7.  Evaluation of patient outcome following sclerotherapy for esophageal varices.

Authors:  M Sumino; A Toyonaga; K Tanikawa
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

8.  Improving prognosis following a first variceal haemorrhage over four decades.

Authors:  P A McCormick; C O'Keefe
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

9.  Upper gastrointestinal bleeding from duodenal vascular ectasia in a patient with cirrhosis.

Authors:  Beom Jae Lee; Jong-Jae Park; Yeon Seok Seo; Ji Hoon Kim; Aeree Kim; Jong Eun Yeon; Jae Seon Kim; Kwan Soo Byun; Young-Tae Bak
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

Review 10.  Acute management of bleeding oesophageal varices.

Authors:  A K Burroughs
Journal:  Drugs       Date:  1992       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.